Real-time enrollment status for this transthyretin amyloidosis clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:14 PM UTC
| NCT Number | NCT05577819 |
| Recruiting Status | Recruiting |
| Condition | Transthyretin Amyloidosis |
| Phase | Clinical Trial |
| Target Enrollment | 515 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | December 9, 2024 (Dec 9, 2024) |
As of July 13, 2026: Clinical trial NCT05577819 is currently recruiting participants. This clinical trial study for transthyretin amyloidosis is actively seeking new participants at 1 location across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05577819 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05577819 was last updated Dec 9, 2024 (December 9, 2024). HelloStudys verifies this status automatically.